You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Parents’ preferences and willingness-to-pay for human papilloma virus vaccines in Thailand
|
|---|---|
| Published in |
Journal of Pharmaceutical Policy and Practice, July 2015
|
| DOI | 10.1186/s40545-015-0040-8 |
| Pubmed ID | |
| Authors |
Surachat Ngorsuraches, Kornwan Nawanukool, Krittin Petcharamanee, Ungkanit Poopantrakool |
| Abstract |
To examine parents' preferences and willingness-to-pay (WTP) for HPV vaccines. A discrete choice experiment (DCE) was used. Parents with at least one daughter aged 9-13 years residing in Songkhla province were asked to choose one alternative from each DCE choice set describing HPV vaccines by four attributes, including cervical cancer risk reduction, genital warts risk reduction, common side effects, and cost. Multinomial logit model was used for data analyses. Parents preferred higher risk reductions for cervical cancer and genital warts, and lower common side effects. They valued the quadrivalent and bivalent HPV vaccines at 21,189.9 and 10,479.9 Baht, respectively. Results also showed that mothers valued both vaccines more than fathers did. Parents valued net benefits for both quadrivalent and bivalent HPV vaccines, but they were willing to pay for the quadrivalent vaccine more than for the bivalent vaccine. |
X Demographics
The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 2 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Science communicators (journalists, bloggers, editors) | 2 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 52 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Canada | 1 | 2% |
| Unknown | 51 | 98% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 13 | 25% |
| Student > Ph. D. Student | 8 | 15% |
| Student > Bachelor | 5 | 10% |
| Researcher | 5 | 10% |
| Student > Postgraduate | 3 | 6% |
| Other | 4 | 8% |
| Unknown | 14 | 27% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 10 | 19% |
| Nursing and Health Professions | 6 | 12% |
| Social Sciences | 6 | 12% |
| Economics, Econometrics and Finance | 5 | 10% |
| Agricultural and Biological Sciences | 3 | 6% |
| Other | 5 | 10% |
| Unknown | 17 | 33% |
Attention Score in Context
This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 21 July 2015.
All research outputs
#15,330,390
of 23,577,654 outputs
Outputs from Journal of Pharmaceutical Policy and Practice
#293
of 432 outputs
Outputs of similar age
#147,100
of 265,420 outputs
Outputs of similar age from Journal of Pharmaceutical Policy and Practice
#2
of 3 outputs
Altmetric has tracked 23,577,654 research outputs across all sources so far. This one is in the 32nd percentile – i.e., 32% of other outputs scored the same or lower than it.
So far Altmetric has tracked 432 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.8. This one is in the 27th percentile – i.e., 27% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 265,420 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 41st percentile – i.e., 41% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 3 others from the same source and published within six weeks on either side of this one.